✉: [email protected]📞: (+91) 12047-40992
53

Research and Reviews: Journal of Oncology and Hematology

2319-3387 Peer‑Reviewed | Subscription‑Based

rrjooh Volume: 15, Issue: 02 Year: 2026

5

Regular Issue  Subscription Original Research Published on :- Jul 03, 2026
By  

 

Mohit Bharat Vishwakarma, Karan Gajajibhai Vala, Padma Mishra, Shubham Mishra,
Abstract : Lung cancer is a global killer because it’s often found late. Finding it early is key to treatment and survival so computer assisted diagnostics are read more

[This section belongs to Research and Reviews: Journal of Oncology and Hematology (rrjooh)]

 

 

Regular Issue  Subscription Review Article Published on :- Aug 31, 2026
By  

 

Deeksha Grover, Rao Moravineni, Oluchi Idenyi, Daniel Assaf, Vishwanath Anil, Madhu Bhargavi Chandra,
Abstract : Introduction: Primary plasma cell leukemia (pPCL) is a rare and aggressive plasma cell dyscrasia, defined by ≥5% circulating plasma cells, with poor read more

[This section belongs to Research and Reviews: Journal of Oncology and Hematology (rrjooh)]

 

 

1-5
Regular Issue  Subscription Review Article Published on :- Aug 31, 2026
By  

 

Diksha Goyal, Surendra Kumar Yadav, Shalini Sharma,
Abstract : One of the main causes of cancer-related death globally is liver cancer, and improving patient outcomes depends heavily on early detection. However, read more

[This section belongs to Research and Reviews: Journal of Oncology and Hematology (rrjooh)]

 

 

39-47
Regular Issue  Subscription Review Article Published on :- Aug 31, 2026
By  

 

Mukesh Chander,
Abstract : Cannabinoids, a complex class of lipophilic compounds found in Cannabis sativa L., are attracting significant clinical interest for their multifaceted read more

[This section belongs to Research and Reviews: Journal of Oncology and Hematology (rrjooh)]

 

 

17-30
Regular Issue  Subscription Review Article Published on :- Aug 31, 2026
By  

 

Khushboo H. Trivedi, Hirenkumar Thakor,
Abstract : Modern healthcare systems are being improved by artificial intelligence (AI) and machine learning (ML), particularly in the treatment of cancer. An read more

[This section belongs to Research and Reviews: Journal of Oncology and Hematology (rrjooh)]

 

 

31-38

Editorial Board

View Full Editorial Board

rrjooh maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Editor in Chief

Editor

Dr. Dillip Kumar Parida, Professor and Head

AIIMS Bhubaneswar, Orissa, India,

Email :


Support